Loading…
Loading…
NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
HCA Healthcare, Inc. ( HCA ) Q3 2026 Earnings Call October 27, 2026 10:00 AM EDT Company Participants Frank Morgan - Vice President of Investor Relations Samuel Hazen - CEO & Director Mike Marks - CFO & Executive VP Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Brian Tanquilut - Jefferies LLC, Research Division Pito Chickering - Deutsche Bank AG, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Sean Dodge - BMO Capital Markets Equity Research Benjamin Mayo - Leerink Partners LLC, Research Division Ryan Langston - TD Cowen, Research Division Sarah James - Cantor Fitzgerald & Co., Research Division Justin Lake - Wolfe Research, LLC Kevin Fischbeck - BofA Securities, Research Division Scott Fidel - Goldman Sachs Group, Inc., Research Division Stephen Baxter - Wells Fargo Securities, LLC, Research Division Jason Cassorla - Guggenheim Securities, LLC, Research Division Raj Kumar - Stephens Inc., Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Andrew Mok - Barclays Bank PLC, Research Division Craig Hettenbach - Morgan Stanley, Research Division Presentation Operator Welcome to the HCA Healthcare Third Quarter 2026 Earnings Conference Call. Today's call is being recorded.
HCA Healthcare NYSE: HCA said third-quarter results modestly exceeded its expectations as admissions growth, improved insured revenue per admission and disciplined cost management helped offset pressure from patients losing health insurance exchange coverage.
HCA's Q3 earnings and revenues beat estimates on higher admissions and ER visits, while rising costs and fewer surgeries temper growth.
U.S.-based hospital HCA Healthcare Inc. (NYSE:HCA) released third-quarter 2026 revenues of $19.849 billion, representing a 3.6% year-over-year increase, beating the consensus estimate of $19.332 billion.
Although the revenue and EPS for HCA (HCA) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
HCA Healthcare (HCA) came out with quarterly earnings of $7.22 per share, beating the Zacks Consensus Estimate of $6.74 per share. This compares to earnings of $6.96 per share a year ago.
[url="]HCA Healthcare, Inc.[/url] (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2026.Key third quarter m